Xue Wu

3PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 06, 2022
Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma.

Dianxing Hu, Ensong Guo, Bin Yang

|Nov 26, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.

Ensong Guo, Rourou Xiao, Yifan Wu

|Aug 12, 2021
WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.

Xue Wu, Xiaoyan Kang, Xiaoxiao Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Chaoyang Sun

1 joint publications

Ensong Guo

1 joint publications

Rourou Xiao

1 joint publications

Yifan Wu

1 joint publications

Funian Lu

1 joint publications

Chen Liu

1 joint publications

Bin Yang

1 joint publications

Xi Li

1 joint publications

Yu Fu

1 joint publications

Zizhuo Wang

Frequent Collaborators

2 joint publications

Chaoyang Sun

1 joint publications

Ensong Guo

1 joint publications

Rourou Xiao

1 joint publications

Yifan Wu

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on : Sep 23, 2021

2.7K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

9.2K
See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

7.4K
<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

<em>In Vivo</em> Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on : Sep 23, 2021

2.7K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on : Apr 03, 2018

9.2K
See more related videos